Skip to Main Content

Paper Details

Dipeptidyl peptidase-4 inhibitor cardiovascular safety in patients with type 2 diabetes, with cardiovascular and renal disease: a retrospective cohort study.
Sci Rep
3
2021
Author NameAffiliation
Omar MansourJohns Hopkins Bloomberg School of Public Health
Omar MansourCenter for Drug Safety and Effectiveness, Johns Hopkins University
George Caleb AlexanderJohns Hopkins Bloomberg School of Public Health
George Caleb AlexanderCenter for Drug Safety and Effectiveness, Johns Hopkins University
George Caleb AlexanderJohns Hopkins Medicine
  • 1 - 5

Datasets

Release 1.2